-
Loading metrics
Open Access
Peer-reviewed
Research Article
Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim
-
Takuya Iyoda ,
Contributed equally to this work with: Takuya Iyoda, Yumi Nagamine, Yoshitomi Nakane, Yuya Tokita
Affiliations Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan, Translational Research Center, Research Institutes for Science and Technology, Tokyo University of Science, Noda, Chiba, Japan
⨯ -
Yumi Nagamine ,
Contributed equally to this work with: Takuya Iyoda, Yumi Nagamine, Yoshitomi Nakane, Yuya Tokita
Affiliation Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan
⨯ -
Yoshitomi Nakane ,
Contributed equally to this work with: Takuya Iyoda, Yumi Nagamine, Yoshitomi Nakane, Yuya Tokita
Affiliation Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan
⨯ -
Yuya Tokita ,
Contributed equally to this work with: Takuya Iyoda, Yumi Nagamine, Yoshitomi Nakane, Yuya Tokita
Affiliation Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan
⨯ -
Shougo Akari,
Affiliation Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan
⨯ -
Kazuki Otsuka,
Affiliation Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan
⨯ -
Motomichi Fujita,
Affiliation Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan
⨯ -
Keisuke Itagaki,
Affiliation Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan
⨯ -
You-ichi Takizawa,
Affiliation Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan
⨯ -
Hiroaki Orita,
Affiliation Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan
⨯ -
Toshiyuki Owaki,
Affiliation Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan
⨯ -
Jyunichi Taira,
Affiliation Department of Biochemistry, Faculty of Science and Engineering, Saga University, Saga, Saga, Japan
⨯ -
Ryo Hayashi,
Affiliation Department of Biochemistry, Faculty of Science and Engineering, Saga University, Saga, Saga, Japan
⨯ -
Hiroaki Kodama,
Affiliation Department of Biochemistry, Faculty of Science and Engineering, Saga University, Saga, Saga, Japan
⨯ -
Fumio Fukai
* E-mail: fukai@rs.noda.tus.ac.jp
Affiliations Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan, Translational Research Center, Research Institutes for Science and Technology, Tokyo University of Science, Noda, Chiba, Japan
⨯
Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim
- Takuya Iyoda,
- Yumi Nagamine,
- Yoshitomi Nakane,
- Yuya Tokita,
- Shougo Akari,
- Kazuki Otsuka,
- Motomichi Fujita,
- Keisuke Itagaki,
- You-ichi Takizawa,
- Hiroaki Orita
- Published: September 13, 2016
- https://doi.org/10.1371/journal.pone.0162525